SARS-CoV-2 Test Development Information

Xpert MRSA NxG

Xpert® MRSA NxG

  • Targeted screening of subjects at high risk for MRSA colonization followed by immediate contact isolation using a rapid on-demand GeneXpert® System has the potential to decrease infection rates and overall hospital costs."

    - Prof. Dr. Michael Walter Charité Universitätsmedizin Berlin & Labor Berlin,
    Charité Vivantes Services GmbH

    The Need

    Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients.

    • Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs
    • Between 2 and 53 million people are estimated to carry MRSA worldwide
    • The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of € 7,478 per patient

    The Solution

    Xpert® MRSA NxG is an accurate, rapid, on-demand PCR test that will help to:

    • Optimize the effectiveness of your infection control program and guide the judicious use of barrier precautions
    • Guide decolonization practices that reduce infection rates and decrease MRSA transmission
    • Help decrease LOS and improve patient and bed management
    • Help reduce infection control costs by limiting unnecessary use of isolation rooms and improve clinical outcomes
    • Detect the presence of MRSA by targeting both the orfX SCCmec junction and the mecA or mecC genes for a more accurate MRSA detection
    • Improve antibiotic stewardship by avoiding unnecessary decolonization
    • Cepheid - Our Vision for a Better Way
    • Catalog #:

      Xpert MRSA NxG
      Number of Tests: 10

    • Catalog #:

      Xpert MRSA
      Number of Tests: 120